TNF Pharmaceuticals, Inc.
Biotechnology
Healthcare
TNFA
5.35 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
3.63
52 week high
6.27
high
3.73
52 week low
0.00
low
3.50
growth
180.80 %
previous Close
3.71
P/E ratio
market cap
1.34 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
51.26 %
eps surprise
0.00 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top